03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Matthew Campbell, PhD
Chair of neurovascular genetics at Trinity College Dublin
press citations on 1 topic since 23 Sept 2026 · last quoted 6 Nov 2026
02 Quoted on · 1 of 29 topics
Matthew Campbell, PhD: key facts
- Kind of voice
- Academic
- Role
- Chair of neurovascular genetics at Trinity College Dublin
- Quoted on
- Diabetes
- Tracked press citations
- 4
- Most recently quoted
- 6 Nov 2026
- First quoted
- 23 Sept 2026
04 The signal · where Matthew Campbell, PhD sits on diabetes
Ranked 29= of 100 voices quoted in the press on diabetes, level with 18 others on 4 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK36 - 2
Dr Elizabeth RobertsonSector leaderDirector of Research and Clinical, Diabetes UK20 - 3=
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)15 - 29=
Dr Kevin FernandoClinicianGP Partner (part-time); portfolio GP, North Berwick Health Centre4 - 29=Colette MarshallSector leaderChief Executive of Diabetes UK4
- 29=Matthew Campbell, PhDAcademicChair of neurovascular genetics at Trinity College Dublin4
- 29=Esther WaldenAcademicsenior clinical advisor at Diabetes UK4
- 29=Charles TaïebClinicianDr, study author4
Showing the leaders and the ranks around 29=, of 100 voices · See every voice on the topic →
05 On the record · press
What Matthew Campbell, PhD has said
- aop.org.uk1
- bbc.com1
- chroniclelive.co.uk1
- insideprecisionmedicine.com1
Where Matthew Campbell, PhD has been quoted
- 01£12m investment in Sunderland hub could use AI to predict if you'll get diabeteschroniclelive.co.uk · 6 Nov 2026
- 02Sunderland project using AI to help eye tests detect diabetesbbc.com · 6 Nov 2026
- 03Researchers examine whether pill could be used to treat diabetic retinopathyaop.org.uk · 29 Oct 2026
- 04Oral Drug Shows Promise in Protecting Against Diabetic Eye Diseaseinsideprecisionmedicine.com · 23 Sept 2026
Verbatim
“The £12.2 million funding is the foundation, not the destination. This investment creates a new health innovation ecosystem for the north-east bringing together Sunderland's clinical and research infrastructure”
“This investment creates a new health innovation ecosystem for the North East.”
“"Our findings demonstrate that a simple oral pill can effectively target and repair the inner blood-retina barrier. This potentially offers a non-invasive, preventive path forward that could protect vision in both eyes simultaneously, long before severe sight loss takes hold," he said.”
“Managing diabetic eye disease before irreversible damage occurs has long been constrained by the burden of invasive injections. Our findings demonstrate that a simple oral pill can effectively target and repair the inner blood-retina barrier. This potentially offers a non-invasive, preventive path forward that could protect vision in both eyes simultaneously, long before severe sight loss takes hold.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.